Tarsier Pharma Files for U.S. IPO, Seeks NYSE Listing Under TARX
Tarsier Pharma Ltd. has submitted paperwork for an initial public offering of its ordinary shares, proposing an offering price between $8.00 and $10.00 per share based on a $9.00 midpoint. The company applied to list on the New York Stock Exchange under the ticker NYSE: TARX and has named Konik Capital Partners as the underwriter. The transaction i…